# Protective Effect of 5-Alpha Reductase Inhibitors on Atherosclerotic Cardiovascular Disease in Populations With BPH: Evidence From UK Biobank Cohort and Chinese Single Center Database Studies

> **NCT07196280** · — · COMPLETED · sponsor: **Chinese PLA General Hospital** · enrollment: 10000 (estimated)

## Conditions studied

- Atherosclerotic Cardiovascular Disease (ASCVD)
- Benign Prostatic Hypertrophy (BPH)

## Interventions

- **DRUG:** 5-Alpha Reductase Inhibitors

## Key facts

- **NCT ID:** NCT07196280
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2025-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07196280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07196280, "Protective Effect of 5-Alpha Reductase Inhibitors on Atherosclerotic Cardiovascular Disease in Populations With BPH: Evidence From UK Biobank Cohort and Chinese Single Center Database Studies". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07196280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*